(Q67126141)

English

Pembrolizumab in Treating Patients With Intermediate or High-Risk Smoldering Multiple Myeloma

clinical trial

Statements

Pilot Single Arm, Single Center, Open Label Trial of Pembrolizumab in Patients With Intermediate and High Risk Smoldering Multiple Myeloma (English)
0 references
20 July 2016
0 references
30 July 2020
0 references
13
0 references
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit